SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price
- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Vivanza Biosciences Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was later on, converted into a Public Limited Company in May, 1992. Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company has a 40- years track record of innovation and success in developing oral drug delivery systems. These technologies have been commercialized in numerous products that are marketed around the world. It has expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections. The Company is focused in commercializing novel and generic pharmaceutical medicines, offering patients better, safe and more accessible medicines. Head quartered in Gujarat, India, the Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. Company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa. The Company came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. The Company acquired 100% Equity Shares of Vivanza Lifesciences Private Limited, making it a Wholly Owned Subsidiary w.e.f. 17 June, 2018. Since competition in the industry is continuously increasing. New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company. Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units.
Vivanza Biosciences share price as on 03 Sep 2026 is Rs. 1.74. Over the past 6 months, the Vivanza Biosciences share price has decreased by 11.22% and in the last one year, it has decreased by 15.12%. The 52-week low for Vivanza Biosciences share price was Rs. 1.52 and 52-week high was Rs. 2.72.
530057
INE984E01035
Sep
Vivanza Biosciences Ltd FAQs
You can buy Vivanza Biosciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vivanza Biosciences Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Sep 03, 2026 03:27 PM the closing price of Vivanza Biosciences Ltd was Rs.1.74.
The latest PE ratio of Vivanza Biosciences Ltd as of Sep 03, 2026 03:27 PM is 16.27
The latest PB ratio of Vivanza Biosciences Ltd as of Sep 03, 2026 03:27 PM is 1.64
The 52-week high of Vivanza Biosciences Ltd share price is Rs. 2.72 while the 52-week low is Rs. 1.52
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 03, 2026 03:27 PM, the market cap of Vivanza Biosciences Ltd stood at Rs. 6.96 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.